Articles > Sports and Life magazines > General Interest magazines > The Saturday Evening Post articles > January 2007

Article: From the pharmacy.(Januvia, Lipitor, Rozerem)

Article from:
The Saturday Evening Post
Article date:
January 1, 2007
Copyright

Editor's Note: Pharmacists are an integral, and sometimes untapped, part of the healthcare maintenance team. If you have a question about medications, write to: Cara Acklin, Pharm.D.; From the Pharmacy; 1100 Waterway Blvd.; Indianapolis, IN 46202.

[X] A Different Kind of Sleeping Pill: Rozerem (generic name: ramelteon) is a new option for people who have trouble falling, but not staying, asleep. The first-of-its-kind prescription drug targets melatonin receptors in the part of the brain that help regulate the body's sleep and wake cycle. Clinical testing shows that Rozerem can be taken occasionally or for months at a time with no risk of dependence or abuse. ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: AbelsonTaylor Wins 57 Honors in Major Ad Competitions, Claiming ...
PR Newswire;  May 14, 2007 ;     700+ words ... ... AbelsonTaylor's professional Rozerem campaign uses two contrasting ... woman to convey the fact that Rozerem, manufactured by Takeda Pharmaceuticals ... communicating the point that Rozerem has no risk for abuse. AbelsonTaylor ... honors for a video supporting a diabetes drug and a gold award for ...

Article: ROZEREM(TM) (ramelteon) Showed Significant Reduction in ...
PR Newswire;  April 3, 2006 ;     700+ words ... ... a Phase III clinical study showed that ROZEREM(TM) (ramelteon) significantly reduced ... thirds of patients who received 8 mg of ROZEREM experienced at least a 50 percent reduction ... following discontinuation of treatment with ROZEREM. Rebound insomnia is the worsening of ...

Article: ROZEREM(TM) (ramelteon) Now Available in U.S. Pharmacies.
PR Newswire;  September 26, 2005 ;     700+ words ... ... North America, Inc. today announced that ROZEREM(TM) (ramelteon) 8-mg tablets are ... characterized by difficulty with sleep onset. ROZEREM is the first prescription insomnia medication ... prescribed for long-term use in adults. ROZEREM is the first and only prescription sleep ...

Article: FDA Approved ROZEREM(TM) (ramelteon), First and Only ...
PR Newswire;  July 22, 2005 ;     700+ words ... ... approved the New Drug Application (NDA) for ROZEREM(TM) (ramelteon) 8-mg tablets for the ... FDA approval allows physicians to prescribe ROZEREM for long-term use in adults. ROZEREM is the first and only prescription sleep medication ...

Article: Study Demonstrated ROZEREM(TM) (ramelteon) Does Not Affect ...
PR Newswire;  June 13, 2007 ;     700+ words ... ... studies presented today demonstrated that ROZEREM did not affect body sway at peak plasma ... data are important because they show that ROZEREM may be a safe sleep medication for the ... patients' memories were not affected by ROZEREM the next morning," said Gary Zammit ...

Article: Ads may jolt pill sales: The FDA approved Takeda Pharmaceuticals' ...
Chicago Tribune (Chicago, IL);  July 16, 2006 ;     700+ words ... ... consumers for its new sleeping pill, Rozerem, which the Food and Drug Administration ... other prescription sleeping aids pose. Rozerem will compete against drugs like Ambien ... about $100 million to launch an array of Rozerem ads, but the company would not confirm ...

Article: Takeda sees new Rozerem tact pay off.(DTC REPORT)(Takeda ...
Medical Marketing & Media;  September 1, 2007 ;     700+ words ... ... campaign for Takeda's insomnia drug Rozerem has generated lots of buzz, but not the ... evolving the campaign to drive trials of Rozerem. The company says two new TV spots that ... prompted more patients to actually mention Rozerem by name when discussing treatment options ...

Article: Unfavorable Tier Placement Makes Safer Insomnia Drug, Takeda's ...
PR Newswire;  October 16, 2006 ;     700+ words ...HMOs' Tier Assignment of Rozerem and Lunesta Ensures Ambien's Status ... benign safety profile, Takeda's Rozerem (ramelteon), the first unscheduled ... percentage of primary care physicians select Rozerem as a first-line agent for primary ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives